Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneManagement of acute exacerbations in multiple sclerosis.Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids.Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.Multiple sclerosis: diagnosis and the management of acute relapsesCerebral venous thrombosis and demyelinating diseases: report of a case in a clinically isolated syndrome suggestive of multiple sclerosis onset and review of the literature.Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.How to run a multiple sclerosis relapse clinic.Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosisCorticosteroids in the management of acute multiple sclerosis exacerbations.Testing for urinary tract colonization before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation.Interferon-beta-1b and interferon-gamma have similar inhibitory effects on apolipoprotein-E production in the monocyte/macrophage.VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
P2860
Q21558407-472E5DC6-99B9-4AD2-A04F-488032518FADQ33670934-04800C5F-A0B1-4A2E-8AC5-D11133636E99Q33733231-83711C0E-BE95-43CD-A209-107799212F41Q34296297-C457DD37-E3BD-474A-9D86-04705565826CQ35476281-619021F1-41B4-4D51-9CAD-55EE6FF5F686Q35521828-38CD2FDB-78D9-41AA-B6F4-CD3BEC2C7039Q36081881-351EE4E4-D682-47A4-B6D3-5FE8456CADFEQ36089049-22D76FD8-233B-41D3-989F-11902E49F850Q36143008-D8AA1B7F-8D00-4367-8AAA-369E7A1CB141Q36577187-1415748E-5F02-4B85-8255-8A77A1D280D7Q37052797-68F7039E-E6D5-4DFF-92F5-866F144C7657Q39229363-86CDB5E6-84B1-4B5D-B70D-7A3870178719Q39582774-D01D1517-692A-43DB-A993-4396F21A9817Q40734433-A71ACF7D-A9C5-4682-A656-61145405BF15Q44219240-0EA28740-6549-4296-B8AD-2D322BAEBBBBQ44699181-53D94381-7BA5-4B70-B00A-00DD7B49A1D8
P2860
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
description
1988 nî lūn-bûn
@nan
1988 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@ast
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@en
type
label
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@ast
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@en
prefLabel
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@ast
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@en
P2093
P2860
P356
P1476
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
@en
P2093
P2860
P304
P356
10.1136/JNNP.51.2.285
P407
P577
1988-02-01T00:00:00Z